Skip to main content
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · IEX Real-Time Price · USD
4.000
-0.280 (-6.54%)
At close: May 17, 2024, 4:00 PM
3.930
-0.070 (-1.75%)
After-hours: May 17, 2024, 4:42 PM EDT

Prelude Therapeutics Market Cap

Prelude Therapeutics has a market cap or net worth of $222.46 million as of May 17, 2024. Its market cap has decreased by -29.29% in one year.

Market Cap
222.46M
Enterprise Value
34.14M
1-Year Change
-29.29%
Ranking
#3584
Category
Micro-Cap
Stock Price
$4.00

Market Cap Chart

Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $222.46M, a decrease of -72.42%. That is a compound annual growth rate of -29.78%.

History

DateMarket Cap% Change
May 17, 2024219.70M-6.55%
May 16, 2024235.10M7.01%
May 15, 2024219.70M3.63%
May 14, 2024212.00M1.58%
May 13, 2024208.70M1.85%
May 10, 2024204.90M-8.36%
May 9, 2024223.60M13.39%
May 8, 2024197.20M-2.95%
May 7, 2024203.20M-3.38%
May 6, 2024210.30M-0.80%
May 3, 2024212.00M-3.24%
May 2, 2024219.10M6.93%
May 1, 2024204.90M-1.06%
Apr 30, 2024207.10M-1.80%
Apr 29, 2024210.90M-5.64%
Apr 26, 2024223.50M0.72%
Apr 25, 2024221.90M4.42%
Apr 24, 2024212.50M-
Apr 23, 2024212.50M0.52%
Apr 22, 2024211.40M3.48%
Apr 19, 2024204.30M8.15%
Apr 18, 2024188.90M-17.73%
Apr 17, 2024229.60M-14.87%
Apr 16, 2024269.70M-12.77%
Apr 15, 2024309.20M0.16%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
OptimizeRx 232.94M
Agenus 228.68M
Eliem Therapeutics 228.44M
Adlai Nortye 226.29M
Ovid Therapeutics 223.48M
Compass Therapeutics 220.14M
Merrimack Pharmaceuticals 220.01M
Innate Pharma 219.07M
Market Cap Rankings